✦ LIBER ✦

High dose ifosfamide, doxorubicin, dacarbazine and G-CSF for patients with metastatic or locally advanced soft tissue sarcoma

✍ Scribed by Lin Tong-yu; Guang Zhong-zhen; Su Yi-sun; Zhou Zhong-mei; Liu Dong-geng

Book ID: 107467117
Publisher: Chinese Anti-Cancer Association
Year: 1999
Tongue: English
Weight: 357 KB
Volume: 11
Category: Article
ISSN: 1000-9604
DOI: 10.1007/s11670-999-0012-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, vincristine, doxorubicin and

Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma

✍ Tom A. Wiklund; Carl P. Blomqvist; Martti Virolainen; Inkeri Elomaa 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 552 KB

855 The use of R-met Hu 6-CSF in combina

855 The use of R-met Hu 6-CSF in combination with high and standard doses of Ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma

✍ M. Erkisi; E. Erkurt; S. Ozbarlas; R. Burgut; F. Doran; E. Seyrek 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Alternating sequential chemotherapy with

Alternating sequential chemotherapy with high-dose ifosfamide and doxorubicin/cyclophosphamide for adult non-small round cell soft tissue sarcomas

✍ Akira Kawai; Toru Umeda; Takuro Wada; Koichiro Ihara; Kazuo Isu; Satoshi Abe; Ta 📂 Article 📅 2005 🏛 Springer Japan 🌐 English ⚖ 121 KB

Results of a phase I dose escalation stu

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide

✍ Sant P Chawla, Arthur Staddon, Andrew Hendifar, Conrad A Messam… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 178 KB

Docetaxel as rescue medication in anthra

Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial

✍ W.J. Koestler; T. Brodowicz; Y. Attems; S. Tomek; M. Hejna; W.C.C. Fiebiger; G. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 195 KB

A phase I/II study of sequential, dose-e

A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas

✍ Carsten Bokemeyer; Anke Franzke; Jörg T. Hartmann; Christoph Schöber; Lubomir Ar 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

ide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in